Name: | Taysha Gene Therapies Inc |
Legal type: | Foreign Corporation |
Status: | Active |
Standing: | Good |
Profit or Non-Profit: | Profit |
File Date: | 20 Jul 2021 (4 years ago) |
Organization Date: | 20 Sep 2019 (6 years ago) |
Authority Date: | 20 Jul 2021 (4 years ago) |
Last Annual Report: | 27 Jun 2024 (10 months ago) |
Organization Number: | 1160228 |
Industry: | Health Services |
Number of Employees: | Small (0-19) |
Principal Office: | 3000 Pegasus Park Drive Suite 1430, Suite 1430, Dallas, TX 75247 |
Place of Formation: | TEXAS |
Name | Role |
---|---|
SEAN NOLAN | Officer |
KAMRAN ALAM | Officer |
Name | Role |
---|---|
KAMRAN ALAM | Secretary |
Name | Role |
---|---|
SUKUMAR NAGENDRAN | President |
RA Session II | President |
Name | Role |
---|---|
SEAN NOLAN | Director |
PHILLIP DONENBERG | Director |
SUKUMAR NAGENDRAN | Director |
LAURA SEPP-LORENZINO | Director |
SEAN STALFORT | Director |
ALISON LONG | Director |
Name | Role |
---|---|
CAPITOL CORPORATE SERVICES, INC. | Registered Agent |
Name | Role |
---|---|
Sarah Davenport | Authorized Rep |
Name | File Date |
---|---|
Annual Report | 2024-06-27 |
Annual Report | 2024-06-27 |
Annual Report | 2023-06-28 |
Annual Report | 2022-06-13 |
Sources: Kentucky Secretary of State